Related Experiment Video
Updated: May 3, 2026

Stretch in Brain Microvascular Endothelial Cells cEND as an In Vitro Traumatic Brain Injury Model of the Blood Brain Barrier
Published on: October 26, 2013
Urapidil as a neuroprotective agent: targeting hypoxia, inflammation, and oxidative stress in traumatic brain injury
Ahmet Bindal1, Pınar Karabacak1, Halil Asci2
1Department of Anesthesiology and Reanimation, Faculty of Medicine, Suleyman Demirel University, Isparta, Türkiye.
Purpose:
One of the important causes of morbidity and mortality in the world is traumatic brain injury (TBI), which is a process that triggers damaging mechanisms such as inflammation, oxidative stress, and apoptosis. The results of current pharmaceutical methods are not enough, and researches into new therapy modalities are needed. This study aimed to evaluate the neuroprotective effects of Urapidil (Ura), which is an alpha-1 adrenergic receptor antagonist with serotonergic activity, in a TBI model and investigating signaling pathways like high mobility group box 1 (HMGB1), BCL2-interacting protein 3-like (BNIP3L), and hypoxia-inducible factor-1 alpha (HIF1α).
Methods:
Thirty-two rats were divided into four groups: control, TBI, TBI + Ura0.5 (0.5 mg/kg), TBI + Ura5 (5 mg/kg) groups. Tissue integrity and expressions of tumor necrosis factor-alpha (TNF-α), caspase-3 (Cas-3), tyrosine hydroxylase (TH), HIF1α, BNIP3L, and HMGB1 were assessed. Ura's biochemical oxidative stress indicators were also assessed.
Results:
Ura treatment at both doses, significantly decreased histopathological findings, BNIP3L, HMGB1, and HIF1α expressions, TNF-α, Cas-3, TH immunexpressions, and TOS and OSI levels, and elevated TAS levels compared to TBI group. These results show that Ura regulates molecular pathways related to TBI, including neuroinflammation, mitochondrial dysfunction, and hypoxia.
Conclusion:
Ura shows promising tissue-protective effects in TBI by targeting inflammation, oxidative stress, and apoptosis. This study provides a new perspective on the need for further development of Ura for therapeutic use.
Insights
Urapidil (Ura) demonstrates significant neuroprotective effects against traumatic brain injury (TBI) in rats. It effectively reduces inflammation, oxidative stress, and cell death by modulating key molecular pathways, offering a promising therapeutic avenue for TBI.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Traumatic brain injury (TBI) is a leading cause of death and disability worldwide.
- Current pharmaceutical treatments for TBI are insufficient, necessitating novel therapeutic strategies.
- TBI involves complex mechanisms including inflammation, oxidative stress, and apoptosis.
Purpose of the Study:
- To investigate the neuroprotective potential of Urapidil (Ura) in a rat model of TBI.
- To evaluate the effects of Ura on molecular signaling pathways implicated in TBI pathogenesis, including HMGB1, BNIP3L, and HIF1α.
Main Methods:
- Thirty-two rats were allocated into control, TBI, and TBI treated with two doses of Ura (0.5 mg/kg and 5 mg/kg).
- Assessment of tissue integrity, inflammatory markers (TNF-α), apoptosis (caspase-3), and key signaling molecules (HIF1α, BNIP3L, HMGB1).
- Evaluation of oxidative stress markers (TOS, OSI, TAS) following Ura treatment.
Main Results:
- Ura treatment significantly reduced histopathological damage, expressions of BNIP3L, HMGB1, HIF1α, TNF-α, caspase-3, and tyrosine hydroxylase in TBI rats.
- Ura administration also decreased oxidative stress markers (TOS, OSI) and increased antioxidant capacity (TAS).
- These findings indicate Ura's ability to modulate neuroinflammation, mitochondrial dysfunction, and hypoxia pathways in TBI.
Conclusions:
- Urapidil exhibits significant tissue-protective effects in a TBI model.
- Ura effectively targets critical pathways involved in TBI, including inflammation, oxidative stress, and apoptosis.
- Further research into Urapidil as a therapeutic agent for TBI is warranted.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Ischemic Stroke ll: Pathophysiology
Traumatic Brain Injury l: Introduction
Cytotoxic Edema: Pathophysiology
Hepatic Encephalopathy
Secondary Spinal Cord Injury llI: Pathophysiology

